AIC
CLB icon

Ameritas Investment Company’s Core Laboratories CLB Stock Holding History

Ameritas Investment Company’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-32
Closed -$921 – 957
2021
Q1 		$921 Buy
+32
New +$1.09K ﹤0.01% 2073
2020
Q2 		– Sell
-23
Closed – – 521
2020
Q1 		$0 Buy
+23
New +$643 ﹤0.01% 1764
2019
Q4 		– Sell
-696
Closed -$32K – 954
2019
Q3 		$32K Buy
+696
New +$32.4K 0.01% 785
2019
Q1 		– Sell
-886
Closed -$53K – 1109
2018
Q4 		$53K Buy
+886
New +$76.5K 0.01% 565

Other funds holding CLB

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameritas Investment Company's CLB Position: Q2 2021 in Review

Ameritas Investment Company sold out of Core Laboratories (CLB) in Q2 2021, closing a stake of 32 shares — an estimated $921 sold.

Ameritas Investment Company first reported a position in CLB in Q4 2018 and held it in 4 quarters. The position peaked at $53K in Q4 2018. 195 funds tracked by Wall St. Rank hold CLB as of Q2 2021.

  • Ameritas Investment Company reported no remaining Core Laboratories position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 32 Core Laboratories shares in Q2 2021, an estimated $921.
  • Ameritas Investment Company first reported a position in Core Laboratories in Q4 2018 and held it in 4 quarters.
  • Ameritas Investment Company's Core Laboratories position peaked at $53K in Q4 2018.
  • 195 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.